- Home
- Publications
- Publication Search
- Publication Details
Title
p53 Family and Cellular Stress Responses in Cancer
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 4, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2014-10-21
DOI
10.3389/fonc.2014.00285
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Preclinical Pharmacokinetics of MI-219, a Novel Human Double Minute 2 (HDM2) Inhibitor and Prediction of Human Pharmacokinetics
- (2016) Peng Zou et al. JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES
- Gain-of-function p53 mutants have widespread genomic locations partially overlapping with p63.
- (2015) Elena Martynova et al. Oncotarget
- Anti-oxidative stress response genes: bioinformatic analysis of their expression and relevance in multiple cancers
- (2015) Barak Rotblat et al. Oncotarget
- Screening for E3-Ubiquitin ligase inhibitors: challenges and opportunities
- (2015) Vivien Landré et al. Oncotarget
- p53-stabilizing Agent CP-31398 Prevents Growth and Invasion of Urothelial Cancer of the Bladder in Transgenic UPII-SV40T Mice
- (2015) Venkateshwar Madka et al. NEOPLASIA
- Regulated Cell Death: Signaling and Mechanisms
- (2014) Avi Ashkenazi et al. Annual Review of Cell and Developmental Biology
- Resistance acquisition to MDM2 inhibitors
- (2014) Jindrich Cinatl et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Small molecule MIRA-1 induces in vitro and in vivo anti-myeloma activity and synergizes with current anti-myeloma agents
- (2014) M N Saha et al. BRITISH JOURNAL OF CANCER
- Mutant p53 in Cancer: New Functions and Therapeutic Opportunities
- (2014) Patricia A.J. Muller et al. CANCER CELL
- SIRT1 is upregulated in cutaneous T-cell lymphoma, and its inhibition induces growth arrest and apoptosis
- (2014) Minakshi Nihal et al. CELL CYCLE
- Essential versus accessory aspects of cell death: recommendations of the NCCD 2015
- (2014) L Galluzzi et al. CELL DEATH AND DIFFERENTIATION
- p53: The barrier to cancer stem cell formation
- (2014) Ronit Aloni-Grinstein et al. FEBS LETTERS
- How theTP53Family ProteinsTP63andTP73Contribute to Tumorigenesis: Regulators and Effectors
- (2014) Eleonora Candi et al. HUMAN MUTATION
- Systemic effects of acute cigarette smoke exposure in mice
- (2014) Masayuki Itoh et al. INHALATION TOXICOLOGY
- After Embedding in Membranes Antiapoptotic Bcl-XL Protein Binds Both Bcl-2 Homology Region 3 and Helix 1 of Proapoptotic Bax Protein to Inhibit Apoptotic Mitochondrial Permeabilization
- (2014) Jingzhen Ding et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- p63 Isoforms Regulate Metabolism of Cancer Stem Cells
- (2014) Simona D’Aguanno et al. JOURNAL OF PROTEOME RESEARCH
- The Sirtuin Inhibitor Tenovin-6 Upregulates Death Receptor 5 and Enhances Cytotoxic Effects of 5-Fluorouracil and Oxaliplatin in Colon Cancer Cells
- (2014) Takunori Ueno et al. ONCOLOGY RESEARCH
- Systems biology of death receptor networks: live and let die
- (2014) I N Lavrik Cell Death & Disease
- The Multifunctional Sorting Protein PACS-2 Regulates SIRT1-Mediated Deacetylation of p53 to Modulate p21-Dependent Cell-Cycle Arrest
- (2014) Katelyn M. Atkins et al. Cell Reports
- Nutlin-3a Efficacy in Sarcoma Predicted by Transcriptomic and Epigenetic Profiling
- (2013) K. I. Pishas et al. CANCER RESEARCH
- p63 regulates glutaminase 2 expression
- (2013) Giacobbe Arianna et al. CELL CYCLE
- The DNA damage checkpoint precedes activation of ARF in response to escalating oncogenic stress during tumorigenesis
- (2013) K Evangelou et al. CELL DEATH AND DIFFERENTIATION
- Danger signalling during cancer cell death: origins, plasticity and regulation
- (2013) A D Garg et al. CELL DEATH AND DIFFERENTIATION
- Dual Targeting of Wild-Type and Mutant p53 by Small Molecule RITA Results in the Inhibition of N-Myc and Key Survival Oncogenes and Kills Neuroblastoma Cells In Vivo and In Vitro
- (2013) M. Burmakin et al. CLINICAL CANCER RESEARCH
- Prima-1 induces apoptosis in bladder cancer cell lines by activating p53
- (2013) CB Piantino et al. Clinics
- Targeting the Ubiquitin-Mediated Proteasome Degradation of p53 for Cancer Therapy
- (2013) Tiffany DeVine et al. CURRENT PHARMACEUTICAL DESIGN
- Mutant p53 Regulates Dicer through p63-dependent and -independent Mechanisms to Promote an Invasive Phenotype
- (2013) Patricia A. J. Muller et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- PRIMA-1Met/APR-246 Displays High Antitumor Activity in Multiple Myeloma By Induction of p73 and Noxa
- (2013) Manujendra N. Saha et al. MOLECULAR CANCER THERAPEUTICS
- TAp73 enhances the pentose phosphate pathway and supports cell proliferation
- (2013) Wenjing Du et al. NATURE CELL BIOLOGY
- Transcriptional regulation of human DNA repair genes following genotoxic stress: trigger mechanisms, inducible responses and genotoxic adaptation
- (2013) M. Christmann et al. NUCLEIC ACIDS RESEARCH
- Poly (C)-Binding Protein 1 Regulates p63 Expression through mRNA Stability
- (2013) Seong-Jun Cho et al. PLoS One
- Impaired epithelial differentiation of induced pluripotent stem cells from ectodermal dysplasia-related patients is rescued by the small compound APR-246/PRIMA-1MET
- (2013) R. Shalom-Feuerstein et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- TAp73 knockout mice show morphological and functional nervous system defects associated with loss of p75 neurotrophin receptor
- (2013) M. V. Niklison-Chirou et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Uncovering the role of p53 splice variants in human malignancy: a clinical perspective
- (2013) Jean-Christophe Bourdon et al. OncoTargets and Therapy
- Caspase Functions in Cell Death and Disease
- (2013) D. R. McIlwain et al. Cold Spring Harbor Perspectives in Biology
- Dysregulation of autophagy in chronic lymphocytic leukemia with the small-molecule Sirtuin inhibitor Tenovin-6
- (2013) Stephanie F. MacCallum et al. Scientific Reports
- A “Twist box” Code of p53 Inactivation: Twist box:p53 Interaction Promotes p53 Degradation
- (2012) Sara Piccinin et al. CANCER CELL
- p53-Mediated Senescence Impairs the Apoptotic Response to Chemotherapy and Clinical Outcome in Breast Cancer
- (2012) James G. Jackson et al. CANCER CELL
- The p53-reactivating small-molecule RITA enhances cisplatin-induced cytotoxicity and apoptosis in head and neck cancer
- (2012) Jong-Lyel Roh et al. CANCER LETTERS
- Small molecules that bind the Mdm2 RING stabilize and activate p53
- (2012) P. Roxburgh et al. CARCINOGENESIS
- Current Advances in the Synthesis and Antitumoral Activity of SIRT1-2 Inhibitors by Modulation of p53 and Pro-Apoptotic Proteins
- (2012) G. Botta et al. CURRENT MEDICINAL CHEMISTRY
- p63/p73 in the control of cell cycle and cell death
- (2012) N. Allocati et al. EXPERIMENTAL CELL RESEARCH
- TAp73 depletion accelerates aging through metabolic dysregulation
- (2012) A. Rufini et al. GENES & DEVELOPMENT
- The sorafenib plus nutlin-3 combination promotes synergistic cytotoxicity in acute myeloid leukemic cells irrespectively of FLT3 and p53 status
- (2012) G. Zauli et al. HAEMATOLOGICA
- Mdm2 antagonists induce apoptosis and synergize with cisplatin overcoming chemoresistance inTP53wild-type ovarian cancer cells
- (2012) Roser Mir et al. INTERNATIONAL JOURNAL OF CANCER
- Crystal Structures of the DNA-binding Domain Tetramer of the p53 Tumor Suppressor Family Member p73 Bound to Different Full-site Response Elements
- (2012) Abdul S. Ethayathulla et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The p63 Protein Isoform ΔNp63α Inhibits Epithelial-Mesenchymal Transition in Human Bladder Cancer Cells
- (2012) Mai N. Tran et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- HDM2 antagonist MI-219 (spiro-oxindole), but not Nutlin-3 (cis-imidazoline), regulates p53 through enhanced HDM2 autoubiquitination and degradation in human malignant B-cell lymphomas
- (2012) Angela M Sosin et al. Journal of Hematology & Oncology
- Pirh2 E3 Ubiquitin Ligase Modulates Keratinocyte Differentiation through p63
- (2012) Yong-Sam Jung et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- p73 haploinsufficiency causes tau hyperphosphorylation and tau kinase dysregulation in mouse models of aging and Alzheimer's disease
- (2012) Gonzalo I. Cancino et al. NEUROBIOLOGY OF AGING
- HuR Is Necessary for Mammary Epithelial Cell Proliferation and Polarity at Least in Part via ΔNp63
- (2012) Wensheng Yan et al. PLoS One
- The p53 network: cellular and systemic DNA damage responses in aging and cancer
- (2012) H. Christian Reinhardt et al. TRENDS IN GENETICS
- MDM2 antagonist Nutlin-3a potentiates antitumour activity of cytotoxic drugs in sarcoma cell lines
- (2011) Hege O Ohnstad et al. BMC CANCER
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- While p73 is essential, p63 is completely dispensable for the development of the central nervous system
- (2011) Lena Holembowski et al. CELL CYCLE
- Non-hominid TP63 lacks retroviral LTRs but contains a novel conserved upstream exon
- (2011) Ulrike Beyer et al. CELL CYCLE
- p63 is a suppressor of tumorigenesis and metastasis interacting with mutant p53
- (2011) G Melino CELL DEATH AND DIFFERENTIATION
- A Phase I First-in-Human Pharmacokinetic and Pharmacodynamic Study of Serdemetan in Patients with Advanced Solid Tumors
- (2011) J. Tabernero et al. CLINICAL CANCER RESEARCH
- p73 as a Pharmaceutical Target for Cancer Therapy
- (2011) Andrea Bisso et al. CURRENT PHARMACEUTICAL DESIGN
- Family friction as ΔNp73 antagonises p73 and p53
- (2011) Sarah G. Bailey et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- p63, a Story of Mice and Men
- (2011) Hans Vanbokhoven et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Mutant p53 gain of function is interwoven into the hallmarks of cancer
- (2011) Hilla Solomon et al. JOURNAL OF PATHOLOGY
- p63 and p73 Isoform Expression in Non-small Cell Lung Cancer and Corresponding Morphological Normal Lung Tissue
- (2011) Marco Lo Iacono et al. Journal of Thoracic Oncology
- New insights into oncogenic stress
- (2011) Kevin M Haigis et al. NATURE GENETICS
- The cancer stem cell: premises, promises and challenges
- (2011) Hans Clevers NATURE MEDICINE
- An integrative genomic approach identifies p73 and p63 as activators of miR-200 microRNA family transcription
- (2011) Emily C. Knouf et al. NUCLEIC ACIDS RESEARCH
- FLASH is essential during early embryogenesis and cooperates with p73 to regulate histone gene transcription
- (2011) A De Cola et al. ONCOGENE
- Acquisition of p53 mutations in response to the non-genotoxic p53 activator Nutlin-3
- (2011) M H Aziz et al. ONCOGENE
- Activation of p53 by Nutlin-3a Induces Apoptosis and Cellular Senescence in Human Glioblastoma Multiforme
- (2011) Ruth Villalonga-Planells et al. PLoS One
- Endogenous retrovirus drives hitherto unknown proapoptotic p63 isoforms in the male germ line of humans and great apes
- (2011) Ulrike Beyer et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The p53 Pathway as a Target in Cancer Therapeutics: Obstacles and Promise
- (2011) A. Mandinova et al. Science Translational Medicine
- Adaptation of cancer cells from different entities to the MDM2 inhibitor nutlin-3 results in the emergence of p53-mutated multi-drug-resistant cancer cells
- (2011) M Michaelis et al. Cell Death & Disease
- Interference with the p53 family network contributes to the gain of oncogenic function of mutant p53 in hepatocellular carcinoma
- (2010) Tobias Schilling et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Dominant negative (ΔN) p63α induces drug resistance in hepatocellular carcinoma by interference with apoptosis signaling pathways
- (2010) Heiko M. Mundt et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Differences in the transactivation domains of p53 family members: a computational study
- (2010) Jagadeesh N Mavinahalli et al. BMC GENOMICS
- ΔNp73β is oncogenic in hepatocellular carcinoma by blocking apoptosis signaling via death receptors and mitochondria
- (2010) André Schuster et al. CELL CYCLE
- p53 directly transactivates Δ133p53α, regulating cell fate outcome in response to DNA damage
- (2010) M Aoubala et al. CELL DEATH AND DIFFERENTIATION
- Dasatinib Plus Nutlin-3 Shows Synergistic Antileukemic Activity in Both p53wild-type and p53mutated B Chronic Lymphocytic Leukemias by Inhibiting the Akt Pathway
- (2010) G. Zauli et al. CLINICAL CANCER RESEARCH
- Interplay between SIRT proteins and tumour suppressor transcription factors in chemotherapeutic resistance of cancer
- (2010) Yolanda Olmos et al. DRUG RESISTANCE UPDATES
- Δ160p53 is a novel N-terminal p53 isoform encoded by Δ133p53 transcript
- (2010) Virginie Marcel et al. FEBS LETTERS
- 40p53 controls the switch from pluripotency to differentiation by regulating IGF signaling in ESCs
- (2010) E. Ungewitter et al. GENES & DEVELOPMENT
- Isoform-specific p73 knockout mice reveal a novel role for Np73 in the DNA damage response pathway
- (2010) M. T. Wilhelm et al. GENES & DEVELOPMENT
- Differential regulation of TP73 isoforms by 1α,25-dihydroxyvitamin D3 and survivin in human colon and breast carcinomas
- (2010) Raquel Díaz et al. GENES CHROMOSOMES & CANCER
- MDM2 antagonist can inhibit tumor growth in hepatocellular carcinoma with different types of p53 in vitro
- (2010) Jiabei Wang et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- The Novel Tryptamine Derivative JNJ-26854165 Induces Wild-Type p53- and E2F1-Mediated Apoptosis in Acute Myeloid and Lymphoid Leukemias
- (2010) K. Kojima et al. MOLECULAR CANCER THERAPEUTICS
- The BCL-2 Family Reunion
- (2010) Jerry E. Chipuk et al. MOLECULAR CELL
- Hypoxia-Inducible Factors and the Response to Hypoxic Stress
- (2010) Amar J. Majmundar et al. MOLECULAR CELL
- PRIMA-1MET/APR-246 targets mutant forms of p53 family members p63 and p73
- (2010) N Rökaeus et al. ONCOGENE
- Pharmacological reactivation of mutant p53: from protein structure to the cancer patient
- (2010) K G Wiman ONCOGENE
- Differential control of TAp73 and Np73 protein stability by the ring finger ubiquitin ligase PIR2
- (2010) B. S. Sayan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- RNPC1, an RNA-binding protein and a target of the p53 family, regulates p63 expression through mRNA stability
- (2010) J. Zhang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- p63 and p73, the Ancestors of p53
- (2010) V. Dotsch et al. Cold Spring Harbor Perspectives in Biology
- Transcriptional Regulation by P53
- (2010) R. Beckerman et al. Cold Spring Harbor Perspectives in Biology
- ΔNp63 knockdown mice: A mouse model for AEC syndrome
- (2009) Maranke I. Koster et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART A
- Targeting p53 for enhanced radio- and chemo-sensitivity
- (2009) Chao Lu et al. APOPTOSIS
- Active transcription of the human FAS/CD95/TNFRSF6 gene involves the p53 family
- (2009) Tobias Schilling et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Deregulated expression of E2F1 promotes proteolytic degradation of tumor suppressor p73 and inhibits its transcriptional activity
- (2009) Toshinori Ozaki et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- MDM2-Dependent Downregulation of p21 and hnRNP K Provides a Switch between Apoptosis and Growth Arrest Induced by Pharmacologically Activated p53
- (2009) Martin Enge et al. CANCER CELL
- Mutant p53 Drives Invasion by Promoting Integrin Recycling
- (2009) Patricia A.J. Muller et al. CELL
- A Mutant-p53/Smad Complex Opposes p63 to Empower TGFβ-Induced Metastasis
- (2009) Maddalena Adorno et al. CELL
- Chemotherapy-induced apoptosis in hepatocellular carcinoma involves the p53 family and is mediatedviathe extrinsic and the intrinsic pathway
- (2009) Sarah J. Seitz et al. INTERNATIONAL JOURNAL OF CANCER
- TAp63 induces senescence and suppresses tumorigenesis in vivo
- (2009) Xuecui Guo et al. NATURE CELL BIOLOGY
- Inhibition of the c-Abl–TAp63 pathway protects mouse oocytes from chemotherapy-induced death
- (2009) Stefania Gonfloni et al. NATURE MEDICINE
- Identification and functional characterization of two new transcriptional variants of the human p63 gene
- (2009) Marina Mangiulli et al. NUCLEIC ACIDS RESEARCH
- Molecular basis of the interactions between the p73 N terminus and p300: Effects on transactivation and modulation by phosphorylation
- (2009) S. Burge et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- DeltaNp73 regulates neuronal survival in vivo
- (2009) F. Tissir et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Transcription-independent p53 apoptosis: an alternative route to death
- (2009) Daniel Speidel TRENDS IN CELL BIOLOGY
- Mutant p53 Gain-of-Function in Cancer
- (2009) M. Oren et al. Cold Spring Harbor Perspectives in Biology
- The Origins and Evolution of the p53 Family of Genes
- (2009) V. A. Belyi et al. Cold Spring Harbor Perspectives in Biology
- The Regulation of the p53-mediated Stress Response by MDM2 and MDM4
- (2009) M. E. Perry Cold Spring Harbor Perspectives in Biology
- The mitochondrial p53 pathway
- (2008) Angelina V. Vaseva et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS
- Discovery, In Vivo Activity, and Mechanism of Action of a Small-Molecule p53 Activator
- (2008) Sonia Lain et al. CANCER CELL
- Therapeutic prospects for p73 and p63: Rising from the shadow of p53
- (2008) Anna Vilgelm et al. DRUG RESISTANCE UPDATES
- TAp73 knockout shows genomic instability with infertility and tumor suppressor functions
- (2008) R. Tomasini et al. GENES & DEVELOPMENT
- MDM2 antagonist nutlin-3 is a potent inducer of apoptosis in pediatric acute lymphoblastic leukemia cells with wild-type p53 and overexpression of MDM2
- (2008) L Gu et al. LEUKEMIA
- YAP and p73: A Complex Affair
- (2008) Julian Downward et al. MOLECULAR CELL
- p73 Regulates Neurodegeneration and Phospho-Tau Accumulation during Aging and Alzheimer's Disease
- (2008) Monica K. Wetzel et al. NEURON
- C-terminal diversity within the p53 family accounts for differences in DNA binding and transcriptional activity
- (2008) M. Sauer et al. NUCLEIC ACIDS RESEARCH
- Small-molecule RETRA suppresses mutant p53-bearing cancer cells through a p73-dependent salvage pathway
- (2008) J. E. Kravchenko et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Temporal activation of p53 by a specific MDM2 inhibitor is selectively toxic to tumors and leads to complete tumor growth inhibition
- (2008) S. Shangary et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Targeted rescue of a destabilized mutant of p53 by an in silico screened drug
- (2008) F. M. Boeckler et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now